Chemours misses Q1 earnings estimates, stock down 2%

Published 06/05/2025, 21:56
Chemours misses Q1 earnings estimates, stock down 2%

WILMINGTON, Del. - Chemours (NYSE:CC) reported first quarter earnings that fell short of analyst expectations, sending its stock down 2.3% in after-hours trading.

The chemical company posted adjusted earnings per share of $0.13, missing the consensus estimate of $0.23. Revenue came in slightly ahead at $1.37 billion versus expectations of $1.36 billion.

Net sales of $1.4 billion were flat compared to the same quarter last year. The company’s Thermal & Specialized Solutions segment saw 40% year-over-year growth in Opteon Refrigerants sales.

However, Chemours swung to a net loss of $4 million in Q1, compared to net income of $54 million in the prior year period. The loss was primarily driven by lower business performance and restructuring charges related to exiting its Surface Protection Solutions Capstone business.

"While we experienced some headwinds across all three businesses, macroeconomic and business-related, we remain steadfast in executing our strategy, focusing on driving long-term shareholder value," said CEO Denise Dignam.

For full year 2025, Chemours expects adjusted EBITDA between $825 million to $950 million. The company also announced a 65% reduction in its quarterly dividend to $0.0875 per share to improve balance sheet flexibility.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.